Company: GANX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001558370-25-005829
Chunk: 56

Company: Gain Therapeutics, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 56
---
982 shares of common stock issuable upon the exercise of options that are exercisable within 60 days of April 25, 2025. |

| (7) | Consists of (a) 27,524 shares of common stock held by Mr. Alder and (b) 30,750 shares of common stock with respect to vested RSUs without consideration of any requirements or conditions that need to be satisfied for such shares to be issued. Upon Mr. Alder’s termination of employment with the Company effective as of June 25, 2024, a portion of his RSU awards (30,750 units) were accelerated to vest and the remainder of the unvested RSU awards (40,126 units) were forfeited. As of April 25, 2025, shares of common stock had not been issued in respect of the vested RSUs. The RSU awards were granted under the 2022 Plan. |

| (8) | Consist of (a) 1,224,742 shares of our common stock held by our directors and current executive officers, (b) 54,900 shares issuable upon vesting of restricted stock units held by our directors, and (c) 833,486 shares of common stock issuable upon the exercise of options granted to our directors and current executive officers that are exercisable within 60 days of April 25, 2025, which does not include shares held by Messrs. Alder or Ballantyne, as they are not current executive officers of the Company. |

40

TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION Policies and Procedures for Related Party Transactions In connection with our initial public offering, our Board adopted a written related-party transaction policy, setting forth the policies and procedures for the review and approval or ratification of transactions involving us and “related persons.” For the purposes of this policy, “related persons” will include (i) our executive officers, directors, director nominees and their immediate family members; (ii) stockholders owning five percent or more of our outstanding common stock and their immediate family members; and (iii) any firm, corporation or other entity in which any of the foregoing persons is employed or is a partner or principal or in a similar position, or in which such person has a 5% or greater beneficial ownership interest. The policy covers with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any transaction, arrangement, or relationship, or any series